SITC 2026 has ended. This guide stays up as the record of who was there. Next: SITC 2027, Nov 3–7, 2027 in National Harbor
U.S. Food and Drug Administration at SITC 2026
Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website
U.S. Food and Drug Administration brings 3 presentations to SITC 2026 in Phoenix. Its program centres on how regulators view new cancer immunotherapies, from safety testing methods to the use of AI in biomarker discovery. One concrete item examines whether biological sex affects key quality measures of CAR T cell products.
| Organization | SITC 2026 Attendance |
|---|---|
U.S. Food and Drug Administration Silver Spring, MD | |
U.S. federal agency that regulates drugs, biologics and medical devices, including cancer immunotherapies. | Session Wed Nov 4 2:10pm–2:55pm Session Wed Nov 4 3:10pm–3:55pm Session Wed Nov 4 4:10pm–4:55pm Poster Fri Nov 6 12:15–1:45pm 5:30–7pm Poster Fri Nov 6 12:15–1:45pm 5:30–7pm |
Find decision makers at U.S. Food and Drug Administration
Tell us what you sell and we’ll find the people at U.S. Food and Drug Administration most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction